Seeking Alpha

Steven Breazzano

 
ABOUT
Steven currently focuses his analyses primarily on the valuation of smaller biotechs (100MM to 1 BB market cap) and utilizes all sources of information, including conversations with management, peer-reviewed publications, SEC filings, and all available primary and secondary research.

Steven is currently a consultant for a New York based life science focused consultancy, and brings a strong scientific and financial background to his current position.

Previously, Steven earned a Ph.D. from the Scripps Research Institute and an M.A. from Columbia University, with extensive work in the field of synthetic and medicinal chemistry, publishing several papers in prestigious peer-reviewed journals. He is also ...More
SNAPSHOT
  • Description: Other. Trading frequency: Monthly
  • Interests: Options, Stocks - long, Stocks - short
COMPANY
Currently, you have no company profile. Click edit to add a company profile.
BLOG
Currently, you have no blog details. Click edit to add blog details.
Book
Currently, you have no book details. Click edit to add book details.
LATEST STOCKTALK more »
Taro Pharmaceuticals: Last Week's Move Is Only The Beginning $TARO http://seekingalpha.com/a/1d6lj Jul 2, 2014